Subject: CNAB is On Fire Big News out Today

SCV Client Spotlight
CNAB is On Fire Big News out Today
Hot Stock to WatchHot Stock to Watch

United Cannabis Corp. (OTCQB: CNAB)


Price: 0.92

Change (%): + 0.07 (8.24)

Volume: 63,931
CNAB Chart

United Cannabis Corp. Files for Patents on Unique Combinations of Pharmaceutically Active Cannabinoids

Patents Relate to Company´s Proprietary Prana Bio Nutrient Medicinals Targeting Disorders of the Nervous System, Immune System and Cancer

Denver, CO / ACCESSWIRE / October 28, 2014 / United Cannabis Corp. (OTCBB: CNAB) (the “Company” or “United Cannabis”) today announced that it has filed for provisional patents related to unique combinations of pharmaceutically active cannabinoids used to treat disorders of the nervous system, immune system and cancer, with the U.S. Patent and Trademark Office.

Using data derived from preclinical and clinical studies, United Cannabis´ research team has identified unique ratios and specifications of cannabinoids that can be used to target the underlying mechanisms of disorders such as PTSD, neuropathy and breast cancer.

Tony Verzura, United Cannabis Chief Technology Officer, commented, “Our focus is not on the treatment of symptoms of disease, but rather on reversing the underlying pathology that drives and contributes to specific disorders. These patents stem from that unique approach and the success we have seen for patients using our Prana products and A.C.T. Now Program.”

Earnie Blackmon, the Company´s Chief Executive Officer, further explains “United Cannabis is dedicated to exploring the role that cannabinoids can play in the field of regenerative medicine, with the goal of not only restoring a balance in physiology but also augmenting the body´s ability to regenerate and heal itself.”

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks